中信建投-九洲药业(603456)2025 results in line with expectations,1Q26 pressured by client patent expiry-260506

登录忘记密码注册

>> 中信建投-九洲药业(603456)2025 results in line with expectations,1Q26 pressured by client patent expiry-260506

上传日期：	2026/5/8	大小：	533KB
格式：	pdf 共6页	来源：	中信建投
评级：	--	作者：	--
下载权限：	此报告为加密报告

相关研报

中信建投-百隆东方(601339)Cotton prices have reached an inflection point,with profit elasticity expected in 2026-260506
中信建投-微泰医疗-B(02235.HK)CGM volume ramp-up drives strong revenue growth,with profit turning positive-260430
中信建投-综合：public REITs 1Q26 performance review_Consumption,affordable rental housing and other sectors see steady growth,while certain pro-cyclical sectors remain under pressure-260429
中信建投-物业服务：overview of service industry 2025 earnings results_Performance pressure gradually eases,and dividend payout is attractive-260428
中信建投-曹操出行(02643.HK)Adjusted profit turned positive for the first time in 25Q4,customized Robotaxi to debut within the year-260427
中信建投-百亚股份(003006)E-commerce operation quality improves in 1Q25,offline key breakthroughs are made,and full-year recovery is expected-260421
中信建投-赛力斯(601127)Maintain high gross margin in 25Q4,while rising expenses and impairments put pressure on performance-260422
中信建投-宏桥控股(002379)Successfully implemented major asset restructuring,awaiting aluminum price rise for new performance highs-260420
中信建投-范式智能(06682.HK)AI platform grows rapidly,API paid business model transformation,and profit gradually releases-260421
中信建投-石油与石化：Fluctuating US-Iran tensions trigger wide-range crude oil volatility-260420

Copyright © 2005 - 2021 Nxny.com All Rights Reserved 备案号：蜀ICP备15031742号-1